Uniklinikum Salzburg, Universitätsinstitut für Innere Medizin III der PMU
Uniklinikum Salzburg, Universitätsinstitut für Innere Medizin III der PMU
Salzburg, Austria1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Platform Trial Evaluating Treatment of Neoadjuvant Trastuzumab-deruxtecan Containing Combination Therapies for HER2+, Resectable Esophagogastric Adenocarcinoma | Esophagogastric Adenocarcinoma | Active, not recruiting | Phase 1 / Phase 2 | 2026-04-21 | NCT06731803 |